Related Experiment Video
Updated: May 24, 2026
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
Gliomatosis peritonei: recurrence, treatment and surveillance
Pablo Menéndez-Sánchez1, Pedro Villarejo-Campos, David Padilla-Valverde
1Servicio de Cirugía General y de Aparato Digestivo, Hospital General de Ciudad Real, Ciudad Real, España. pablomensan@hotmail.com
Background:
Gliomatosis peritonei is the metastatic implantation of mature glial tissue within the peritoneal cavity of patients with ovarian teratomas. There is no clear guidance for how long these patients should be followed up.
Clinical Case:
We report the follow-up imaging findings of a 33-year-old female with abdominal distension and abdominal pain and who was postoperatively diagnosed with immature ovarian teratoma with gliomatosis peritonei.
Conclusions:
Differentiation of peritoneal implants seems to be important for prognosis. Malignant transformations after several years cannot be excluded. Therefore, new studies will determine if it is necessary to create guidelines for the postsurgical monitoring of these patients.
